Eosinophilic Disease

Resource Center

FDA Alerts

treatment

FDA Approves First EoE Treatment

05/28/2022

The FDA has approved the first treatment for eosinophilic esophagitis.

05/28/2022

asthma

FDA Approves New Option for Severe Eosinophilic Asthma

11/15/2017

The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.

11/15/2017

News

Airway

Airway Differentiation for Eosinophilic Diseases

05/31/2022

Researchers examined how airway differentiation of eosinophilic progenitor cells may impact non-asthmatic eosinophilic bronchitis and eosinophilic asthma.

05/31/2022

treatment

FDA Approves First EoE Treatment

05/28/2022

The FDA has approved the first treatment for eosinophilic esophagitis.

05/28/2022

symptoms

Dilation, Eosinophils in Eosinophilic Esophagitis

04/30/2022

Dilation of the esophagus is often used to manage symptoms of dysphagia in patients with eosinophilic esophagitis, but the relationship between dilation, eosinophil concentration, and symptoms in these...

04/30/2022

treatment

Biologics as Treatment Alternative for Hypereosinophilic Syndrome

04/26/2022

Although immunomodulators are often used to treat HES, a group of rare conditions characterized by a persistently higher than normal level of eosinophils and evidence of organ damage, biologics may be a...

04/26/2022

outcomes

Allergic, Eosinophilic Asthma Patients Have Better COVID-19 Outcomes

03/31/2022

COVID-19 has had an especially substantial effect on those with chronic diseases such as asthma. Researchers examined the impact of various asthma phenotypes as a COVID-19 comorbidity or as a risk factor...

03/31/2022

July 2022

Current Issue

July 2022